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Summary Consistent chromosomal translocations involving the c-myc cellular oncogene and one of the three
immunoglobin loci are typical for human Burkitt's lymphoma, induced mouse plasmacytoma (MPC) and
spontaneously arising rat immunocytoma (RIC). Another plasma cell malignancy, multiple myeloma (MM),
arising spontaneously in the ageing C57BL/KaLwRij mice, was investigated in order to see whether the MM
cells contain c-myc abnormalities of the MPC or RIC type. Rearrangement of the c-myc oncogene was found
in the bone marrow cells only in 5T2 MM transplantation line in a mouse of the 24th generation and in none
of the seven other MM of the 5T series which were of earlier generations. Since the mouse 5T MM resembles
the human MM very closely, including the absence of consistent structural c-myc oncogene abnormalities, it
can serve as a useful experimental model for studies on the aetiopathogenesis of this disease.
Consistent chromosomal translocations involving the c-myc
cellular oncogene and one of the three immunoglobulin loci
have been reported in human Burkitt's lymphoma, in
induced mouse plasmacytoma (MPC) and in spontaneously
arising rat immunocytoma (RIC) (reviewed by Croce &
Nowell, 1985; Potter, 1986; Pear et al., 1986; Enrietto, 1987).
Translocation is believed to play an important role in the
development of these tumours (Klein, 1986). Multiple
myeloma (MM) in humans is a neoplasm of B cells at a
differentiation stage comparable to that of MPC and RIC.
However, a rearrangement of the c-myc oncogene was
reported only in three cases of MM (Gazdar et al., 1986;
Selvanayagam et al., 1988) and in one case of plasma cell
leukaemia (Yamada et al., 1983).
In recent years, several transplantation lines derived from
spontaneously arising MM in ageing C57BL mice became
available in our institute. This mouse MM resembles the
human disease very closely in several aspects (Radl et al.,
1988). It is of interest to investigate whether the cells of the
experimental ST MM series contain c-myc abnormalities of
the MPC type or whether they resemble the human MM in
this respect. The results of this study show that rearrange-
ment of the c-myc oncogene was found in the bone marrow
of only one of the ST MM transplantation lines and was
possibly due to a late event in the progression of this malig-
nancy.
Materials and methods
Mice
Male and female C57BL/KaLwRij mice from the colony of
the Institute for Experimental Gerontology in Rijswijk, The
Netherlands, were used in this study. Detailed information
on this inbred strain of mice has been published elsewhere
(Zurcher et al., 1982; Van Zwieten et al., 1981).
ST mouse multiple myeloma
The different ST MM originated spontaneously in ageing
C57BL/KaLwRij mice (Radl et al., 1988). The individual ST
MM were further propagated by intravenous transfer of bone
marrow or spleen cells into young recipients of the same
strain. An attempt was also made to grow the individual ST
MM in an ascitic form by transplanting bone marrow cells
into the peritoneal cavity of young recipient mice. In four
instances this was successful. The main characteristics of the
individual 5T MM lines pertinent to this study are given in
Table I.
Cellpreparations
Cell suspensions from bone marrow and spleen were
prepared as described (Croese et al., 1987). The percentage of
5T MM cells in these samples was estimated by morphology,
cytoplasmic immunoperoxidase staining and by analysis of
the cellular DNA content. Cytoplasmic examination was per-
formed on cytocentrifuge preparations (Hijmans et al., 1965)
of the suspensions, using PO-labelled antibodies (Nordic
Immunological Laboratories, Tilburg, The Netherlands)
specific for the isotype of the given 5T MM immunoglobulin
(Table I). The DNA from bone marrow or spleen cells was
stained with propidium iodine (PI) according to Taylor
(1980). The cellular DNA content was analysed by measuring
the PI fluorescence intensity by a fluorescence-activated cell
sorter (FACS-II, Becton Dickinson, Mountain View, CA,
USA).
Southern blot analysis
High molecular weight DNA was extracted from 0.5-1.0
x I0 bone marrow, spleen or ascitic cells by the method of
Kunkel et al. (1977). The chromosomal DNA was digested
with the restriction enzymes HindIII or EcoRI under condi-
tions recommended by the manufacturer (Gibco-BRL, Breda,
The Netherlands). Digested DNA was electrophoresed on
0.6-0.8% agarose gels in buffer consisting of 89 mM Tris,
89 mM boric acid and 0.2 mM EDTA, pH 8.0 and transferred
to Gene Screen Plus filters in 0.4 N NaOH and 0.6 M NaCI
(Reed & Mann, 1985). Filters were prehybridised for 2 h at
65'C in a solution of 50 mM Tris/HCl, pH 7.5, 10 mM
EDTA, 1 M NaCl, 1% SDS, 0.1% sodium pyrophosphate,
0.2% Ficoll, 0.2% polyvinylpyrrolidone, 100 xg ml- salmon
sperm DNA and hybridised in the same solution overnight
with 25 ng of c-myc probe, with specific activity of approx-
imately 109 c.p.m.tig-' DNA, a 1.4 kb ClaI-EcoRI fragment
containing the third exon of the human c-myc gene, which
was random-primed 32P-labelled (Boehringer, Mannheim,
FRG). After hybridisation, filters were washed to a strin-
gency of 0.5 x SSC (I SSC = 75 mM NaCl, 7.5 mM sodium
citrate, 1% SDS) 0.1% sodium pyrophosphate at 65'C, and
exposed overnight at - 70'C to Kodak XAR-5 X-ray films.
A schema of the murine c-myc gene and the relevant restric-
tion sites are shown in Figure 1.
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Table I C57BL/KaLwRij mouse 5T multiple myeloma lines of spontaneous origin
ST MM Transplantation
no. Isotype generation Growth pattern Remark
5T2 IgG2a-k 24 moderately several sublines
(17) progressive (also ascitic form)
5T7 IgG2b-k 7 'smouldering MM'
5TI3 IgG2b-k 4 moderate
5T14 IgGl-k 10 aggressive different sublines
(59) (also ascitic form)
5T21 IgD-k 11 atypical
5T30 IgG2a-k 3 aggressive
(3) (also ascitic form)
5T33 IgG2b-k 5 moderately
(34) progressive (also ascitic form)
5T41 IgG3-k I moderate
Generations of the MM in ascitic form are given in parentheses.
c-myc I-1000 bp 14 Kb germ line
Figure 1 Molecular map of the murine c-myc gene. Restriction
sites: RI, EcoRI; Hd, HindIII. The third exon probe used is
denoted by a black box.
Sensitivity ofthe technique and controls
Bone marrow cells from normal mice and from RPC-20
mouse plasmacytoma with a known c-myc rearrangement
were used as controls. The detection sensitivity limit of the
c-myc rearrangement in this technique was determined by
admixing isolated SP2/0 hybridoma cells to normal bone
marrow cells in different proportions and was found to be
about 3-4%. In the different 5T MM preparations, the
percentages of MM cells varied from 15 to 70% and from 7
to 44% for bone marow and spleen cells, respectively.
Results
No rearrangement of the c-myc oncogene was found in any
of the individual ST MM (Table I) when spleen cells were
investigated. Similar results were obtained when bone mar-
row cells were analysed, however, with one exception. The
mouse 5T7, 5T13, 5T14, 5T21, 5T30, 5T33 and 5T41 MM
showed only the germ line fragments of 4.6 kb (HindIII) and
22 kb (EcoRI) as in normal mouse bone marrow (Figure 2).
However, the 5T2 MM showed an additional hybridising
fragment of 5.4 kb (HindIII) and 15 kb (EcoRI). The same
pattern was observed when DNA from 5T2 MM cells
originating from an animal with an ascitic form of 5T2 MM
was investigated (Figure 3). This indicates that the c-myc
rearrangement took place in the common donor of both
sublines in an earlier generation.
Three other ST MM were shown to be able to grow in the
peritoneal cavity of unprimed recipient mice: 5T14, 5T30 and
5T33 MM. The DNA isolated from the 5T30 and 5T33 MM
showed only the germ line configuration, while that of the
5T14 MM produced an additional band of 1.3 kb (HindIII)
and 5.8 kb (EcoRI) (Figure 3).
Discussion
The most common structural alteration in human Burkitt's
lymphoma, mouse plasmacytoma and rat immunocytoma is
an interruption of the c-myc gene upstream of its second
exon (Mushinski et al., 1987). In many MPC, the breakpoint
is within the first intron between El and E2, in some MPC,
the breakpoint in c-myc occurs 300-500 base pairs 5' of El
(Potter, 1986). This kind of abnormality, indicated by a
rearrangement of the c-myc oncogene within the bone mar-
row tumour cells of the ST MM series was found only in the
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Figure 2 Autoradiogram of DNA from bone marrow cells
digested with HindIII (lanes 1-7) and EcoRI (lanes 8-14). Lanes
I and 8, 5T2; lanes 2 and 9, 5T7; lanes 3 and 10, 5T14; lanes 4
and 11, 5T33; lanes 5 and 12, 5T41; lanes 6 and 13, RPC-20;
lanes 7 and 14, normal bone marrow cells. Analyses of MM
5T13, 5T21 and 5T30 are not shown. For details see the text.
5T2 MM bearing mouse in the 24th transplantation genera- tion and in none of the seven other ST MM, which were of
earlier generations. The bone marrow is the major site of this
malignancy in both man and the C57BL mouse (Radl et al., 1988). Therefore, any structural abnormalities within
different oncogenes, if they were of basic importance for the
development of this malignancy, should primarily be present in the MM cells of the bone marrow compartment. In
humans, rearrangement of the c-myc oncogene was found
only in three cases (one of them being a very progressive IgA MM involving pleural tissue) and in one case of plasma cell
leukaemia (Gazdar et al., 1986; Selvanayagam et al., 1988; Yamada et al., 1983). In this context, it is interesting that in
the 5T14 MM, being able to grow in the peritoneal tissue, a
rearrangement of the c-myc was found in ascitic cells but not
in the bone marrow cells. Moreover, the 5T2 MM in an
advanced stage can develop features of a plasma cell
leukaemia (Ebbeling et al., 1985). These findings indicate that
structural abnormalities of the c-myc oncogene of the most
common MPC types are not a prerequisite for the develop-
ment of MM. Our data, together with those of others on
human MM, can be interpreted as indicating that such re-
arrangement can take place, possibly as a late event in the
progression of this malignancy or due to its location in
peritoneal or pleural tissue, where it can obtain selective
growth advantage. Our investigation does not exclude some
other structural abnormalities which would occur outside the
analysed region.
Cytogenetic investigations performed in this multiple
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Figure 3 Autoradiogram of DNA from ascitic cells digested with
HindIII (lanes 1-5) and EcoRI (lanes 6-9). Lane 1, 5T2; lanes 2
and 6, 5T14; lanes 3 and 9, 5T33; lanes 4 and 8, RPC-20; lane 5,
normal bone marrow cells. Analysis of 5T30 MM is not shown.
myeloma of the 5T series (Th.W. van den Akker et al., in
preparation) showed near triploid chromosome numbers in
four lines (5T2, 5T7, 5T14 and 5T41) and hypotetraploid
numbers in one (5T33). All karyotypes showed one or two
copies of normal chromosome 15 and markers involving
chromosome 15. 5T2 and 5T14 (transplant generation 11)
showed markers with partial deletion of chromosome 15. No
consistent abnormalities involving chromosomes 6, 12 or 16
with the three immunoglobulin gene loci were found. To
detect more subtle changes, if present, within the first exon of
the myc gene, studies on the myc RNA message will be
performed after establishing cell lines of the ST multiple
myelomas in vitro (work in progress).
The human MM and the mouse ST MM show a close
resemblance in several aspects (RadI et al., 1985, 1988),
including possibly also the c-myc pattern. Therefore, these ST
MM series offer an excellent experimental model for studies
on the aetiology and pathogenesis of multiple myeloma. In
addition, this mouse B cell malignancy, expressed mainly at
the differentiation stage of a plasma cell, shows clear-cut
differences when compared with MPC and RIC, both also
involving a B cell at its last differentiation stage (Radl et al.,
1988). Investigation of these differences may shed new light
on the possible microheterogeneity of the plasma cell and its
malignant counterparts evolving either into local plas-
macytoma or diffuse multiple myeloma.
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